A Single and Multiple Dose Study of Lemborexant in Healthy Chinese Participants

NCT04555733 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: Lemborexant

Sponsor

Eisai Co., Ltd.